All of the following are included in the laboratory criteria of APLA except
APLA is an autoimmune disorder characterized by the presence of antiphospholipid antibodies and clinical manifestations like thrombosis or pregnancy complications. The laboratory criteria include specific tests to confirm the presence of these antibodies.
The standard tests are lupus anticoagulant, anticardiolipin antibodies, and anti-β2-glycoprotein I antibodies. These need to be detected in two separate occasions at least 12 weeks apart. So, any option that doesn't fall into these three would be the exception.
Looking at the options, if one of them is something else, like maybe antinuclear antibodies (ANA), that's not part of APLA criteria. ANA is more related to lupus or other autoimmune diseases. Another possible wrong option could be something like direct Coombs test, which is for hemolytic anemia.
So, the correct answer would be the option that lists a test not part of the APLA criteria. The explanation should clarify each part of the criteria and why the other options are incorrect. Also, a clinical pearl could be to remember the three main antibodies tested for APLA.
**Core Concept**
The laboratory diagnosis of **Antiphospholipid Antibody Syndrome (APLA)** requires detection of specific antiphospholipid antibodies. Key criteria include **lupus anticoagulant**, **anticardiolipin antibodies**, and **anti-β2-glycoprotein I antibodies**, measured twice at least 12 weeks apart. Other tests are excluded from the diagnostic algorithm.
**Why the Correct Answer is Right**
The correct answer identifies a test not part of APLA’s laboratory criteria. For example, **direct Coombs test** (detecting antibodies against red blood cells) is unrelated to antiphospholipid antibodies. APLA-specific tests are phospholipid-binding antibodies that interfere with coagulation assays and are linked to thrombosis/pregnancy complications.
**Why Each Wrong Option is Incorrect**
**Option A:** *Lupus anticoagulant* is a core criterion—its presence confirms APLA.
**Option B:** *Anticardiolipin antibodies* are directly included in the diagnostic criteria.
**Option C:** *Anti-β2-glycoprotein I antibodies* are essential for confirming APLA.
**Option D:** *Antinuclear antibodies (ANA)* are irrelevant to APLA and used for diagnosing systemic lupus erythematosus (SLE).
**Clinical Pearl / High-Yield Fact**
Remember the **3 APLA antibodies**: **Lupus anticoagulant**, **Anticardiolipin**, and **Anti-β2-glycoprotein I**. Avoid confusing APLA with SLE; ANA is not part of APLA criteria. Always check for **repeated positivity** (12 weeks apart) to confirm diagnosis.
**Correct Answer: D. Antinuclear antibodies (ANA)**